Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Loss

v2.4.0.6
Consolidated Statements of Loss (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Consolidated Statements of Loss [Abstract]      
COLLABORATION REVENUE $ 5,496 $ 13,616 $ 25,539
EXPENSES      
Research and development 21,553 18,483 20,209
General and administrative 6,230 5,840 3,961
Restructuring expense [note 7]   4,038 3,951
Total expenses 27,783 28,361 28,121
OTHER INCOME (EXPENSE)      
Interest income 220 86 47
Other 6 6 70
Warrant issuance costs   (1,027)  
Gain on warrants 7,388 96  
Total other income (expense) 7,614 (839) 117
Loss for the period before taxes (14,673) (15,584) (2,465)
Income tax expense (recovery) [note 9]   (3,000) 3,011
Net loss attributable to common shareholders $ (14,673) $ (12,584) $ (5,476)
Basic and diluted net loss per common share [note 10[g]] $ (1.51) $ (1.79) $ (0.95)
Weighted average number of common shares [note 10[g]] 9,729,340 7,030,903 5,766,850